← Back to Search

Device

Spinal Cord Stimulation for Pain

N/A
Waitlist Available
Research Sponsored by MedtronicNeuro
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
22 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 16 months
Awards & highlights

Study Summary

This trial is testing different types of stimulations to see what works best for pain relief with the least side effects.

Who is the study for?
This trial is for adults over 22 with limb or back pain, who have had a Medtronic rechargeable neurostimulation system implanted for at least one month. Participants must understand English, be able to follow the study's procedures and document their experience. Pregnant women or those not using birth control are excluded.Check my eligibility
What is being tested?
The SCS Research Study is examining how different spinal cord stimulation settings affect pain relief in patients with chronic limb and back pain. It focuses on personalizing treatment by assessing outcomes specific to each participant.See study design
What are the potential side effects?
While the summary doesn't specify side effects, spinal cord stimulation can typically cause discomfort at the site of implantation, unwanted tingling sensations due to stimulation, and potential infection risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 22 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 16 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 16 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Numeric pain rating scale

Side effects data

From 2019 Phase 4 trial • 30 Patients • NCT03284411
10%
Device stimulation issue
3%
Inadequate analgesia
3%
Back pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Spinal Cord Stimulation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Spinal Cord StimulationExperimental Treatment1 Intervention
Each subject will be programmed to different settings.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spinal Cord Stimulation
2020
Completed Phase 4
~90

Find a Location

Who is running the clinical trial?

MedtronicNeuroLead Sponsor
69 Previous Clinical Trials
20,459 Total Patients Enrolled

Media Library

Spinal Cord Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT03763708 — N/A
Limb Pain Research Study Groups: Spinal Cord Stimulation
Limb Pain Clinical Trial 2023: Spinal Cord Stimulation Highlights & Side Effects. Trial Name: NCT03763708 — N/A
Spinal Cord Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03763708 — N/A
Limb Pain Patient Testimony for trial: Trial Name: NCT03763708 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA sanctioned Spinal Cord Stimulation as a therapeutic option?

"Clinical data has been collected over many years, indicating Spinal cord Stimulation is a safe procedure. Consequently, it was given the highest rating of 3 on our scale."

Answered by AI

How many volunteers are participating in the experiment?

"Indeed, the information provided on clinicaltrials.gov demonstrates that this medical experiment is currently searching for participants. This trial was first published in December 2018 and last updated June 2022; it requires 360 subjects across 10 different sites."

Answered by AI

Are there current openings for this research endeavor?

"That is accurate. According to the details on clinicaltrials.gov, this study was initially posted in December 2018 and recently updated in June 2022. The trial currently seeks 360 participants spread across 10 medical sites."

Answered by AI

Where is the oversight of this trial administered?

"Ten medical facilities have been selected to participate in this trial, among which are Twin Cities Pain Clinic situated in Edina, University of California San Diego Altman Clinical and Translational Research Institute located in La Jolla, Centre for Interventional Pain and Spine based out of Lancaster. Furthermore, there are several other research sites participating."

Answered by AI

Who else is applying?

What state do they live in?
California
North Carolina
How old are they?
18 - 65
What site did they apply to?
Center for Pain and Supportive Care
Carolinas Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I have persistent back and leg pain.
PatientReceived 1 prior treatment
~168 spots leftby Jan 2029